Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

A com­pa­ny with pub­lic links to Sanofi and Mod­er­na has raised more mon­ey to ex­pand its mis­sion of im­prov­ing di­ver­si­ty and en­roll­ment in clin­i­cal tri­als.

Ina­to put the word out on Wednes­day that it raised $20 mil­lion via an A2 round to ad­vance its match­ing plat­form be­tween phar­ma com­pa­nies and po­ten­tial clin­i­cal tri­al sites.

Ina­to CEO Kourosh Davarpanah told End­points News that with the $20 mil­lion in hand, it will pur­sue im­prove­ments to its di­ver­si­ty of­fer­ings, its fo­cus on on­col­o­gy and da­ta col­lec­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER